Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Definitive chemoradiation for oligometastatic esophageal cancer patients.
Authors
Lindsay Puckett
Medical College of Wisconsin, Milwaukee, WI
Lindsay Puckett , Thomas Matoska , Lauren Jurkowski , Anjishnu Banerjee , Enrique Martinez , Divya Kodali , Monica Shukla , Paul Linsky , Mario Gasparri , Sakti Chakrabarti , Ben George , Aditya V. Shreenivas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Other
DOI
10.1200/JCO.2022.40.4_suppl.359
Abstract #
359
Poster Bd #
J2
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Impact of palliative care in patients with metastatic esophageal cancer declining chemotherapy.
First Author: Nicholas Manguso
Poster
2014 Gastrointestinal Cancers Symposium
A comparison of carboplatin with paclitaxel and cisplatinum with 5-fluorouracil in definitive chemoradiotherapy in esophageal cancer patients.
First Author: Judith Honing
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A randomized phase III study comparing 2-weekly docetaxel, cisplatin and 5-FU (bDCF) with cisplatin and 5-FU (CF) in patients with metastatic or recurrent esophageal cancer: JCOG1314 (MIRACLE).
First Author: Takahiro Tsushima
Poster
2024 ASCO Gastrointestinal Cancers Symposium
An observational study on treatment patterns and outcomes among patients with metastatic or recurrent esophageal cancer: Real-world data and empirical analyses in Japan (POME).
First Author: Shun Yamamoto